期刊文献+

CD4^+CD25^+调节性T细胞在维持小鼠肝脏移植自发性免疫耐受状态中的作用 被引量:4

Impact of CD4^+CD25^+ Regulatory T Cells in Maintenance of Spontaneous Immunotolerance in Mouse Liver Transplantation
原文传递
导出
摘要 目的探讨CD4+CD25+调节性T细胞在维持小鼠肝脏移植免疫耐受状态中的作用。方法进行小鼠原位肝脏移植,诱导出移植免疫耐受后,向受体注射抗CD25抗体(PC61)以去除CD4+CD25+T细胞,检测受体内CD4+CD25+T细胞数量及叉状头/翅膀状螺旋转录因子(Foxp3)的表达以确定CD4+CD25+T细胞完全被清除,同时观察受体生存时间。结果与同种同系小鼠肝脏移植结果相似,同种异系肝脏移植小鼠的生存时间亦均超过70 d。移植免疫耐受诱导后,PC61不同注射方案均能完全去除受体小鼠肝脏、脾脏及血液中的CD4+CD25+T细胞,且移植肝脏中Foxp3 mRNA的表达也明显降低,表明完全去除了CD4+CD25+调节性T细胞,但肝脏移植动物生存时间并未受到影响。结论 CD4+CD25+调节性T细胞对于小鼠肝脏移植自发性免疫耐受的维持并非必需。 Objective To approach the role of CD4^+ CD25^+ regulatory T cells in the maintenance of immuno- tolerance in mouse liver allograft. Methods The mouse orthotopic liver transplantation was performed. After the liver transplantation immunotolerance induction, anti-CD25 monoclonal antibody (PC61) was injected into the recip- ients with a delayed timing to remove the CD4^+ CD25^+ T cells. The percentage of CD4^+ CD25^+ T cells and the ex pression of fork-head/winged helix transcription factor (Foxp3) in the recipients were examined. Furthermore, the survival time of the recipient was observed. Results C3H/HeJ recipients receiving DBA/2 hepatic allografts sur vived over 70 d as in the syngeneic liver transplantation (C3H/HeJ recipients receiving C3H/HeJ hepatic grafts). With various protocols of the delayed PC61 treatment, the CD4^+ CD25^+ T cell was completely disappeared as ob- served. However, the removal of CD4^+ CD25^+ regulatory T cells after the induction of transplantation immunotoler ance did not affect the survival of hepatic allografts. Conclusion CD4^+ CD25^+ regulatory T cells are not essential for the maintenance of spontaneous mouse liver transplantation immunotolerance.
出处 《中国普外基础与临床杂志》 CAS 2011年第4期366-369,共4页 Chinese Journal of Bases and Clinics In General Surgery
基金 教育部留学回国人员科研启动基金资助项目(项目编号:2008890) 辽宁省教育厅高等学校科研项目计划(项目编号:2008824)~~
关键词 CD4^+CD25^+调节性T细胞 小鼠 肝脏移植 移植免疫耐受 CD4^+CD25^+ regulatory T cell Mouse Liver transplantation Transplantation immunotoler-ance
  • 相关文献

参考文献3

  • 1Sakaguchi S. Naturally arising Foxp3-expressing CD25^+ CD4^+ regulatory T cells in immunological tolerance to self and non-self[J]. Nat Immunol, 2005, 6(4): 345-352.
  • 2Pandiyan P, Zheng L, Ishihara S, et al. CD4^+ CD25^+ Foxp3^+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4^+ T cells [J]. Nat Immunol, 2007, 8 (12): 1353-1362.
  • 3Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans [J]. Nat Rev Immunol, 2007, 7(8): 585-598.

同被引文献38

  • 1梁廷波,俞志勇,郑树森.非T细胞来源细胞因子在小鼠心脏移植急性排斥反应模型中的表达[J].中华医学杂志,2006,86(1):26-30. 被引量:3
  • 2李向东.器官移植排斥反应检测新进展[J].检验医学,2006,21(5):547-550. 被引量:2
  • 3彭启全,李升平,徐立,李锦清.117例肝癌患者外周血调节T细胞水平及其临床意义[J].癌症,2007,26(7):748-751. 被引量:18
  • 4Llovet JM, Burroughs A, Bruix J, etal. Hepatocellular carcinoma [J]. Lancet, 2003, 362(9399): 1907-1917.
  • 5Noritoshi K, Nobuyoshi H, Wataru Y, etal. FOXP^3+ regu- latory T cells affect the development and progression of hepatocarcinogenesis [J]. Clin Cancer Res, 2007, 13(3): 902- 911.
  • 6Morse MA, Clay TM, Mosca P, et al. Immunoregulatory T cells in cancer immunotherapy [J]. Expert Opin Biol Ther, 2002, 2(8) : 827-834.
  • 7Randolph DA, Fathman CG. Garrison FC. CD^4+CD^25+ regulatory T cells and their therapeutic potential [J]. Annu Rev Meal, 2006, 57: 381-402.
  • 8Llovet JM, Di Bisceglie AM, Bruix J, etal. Design and endpoints of clinical trials in hepatocellular carcinoma [J]. Commentary JNCI, 2008, 100(10) ; 698-711.
  • 9Waldmann TA. Effective cancer therapy through immunomodulation [J]. Annu Rev Med, 2006, 57: 65-81.
  • 10Fu JL, Xu DP, Liu ZW, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients [J]. Gastroenterology, 2007, 132(7): 2328-2339.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部